MXCT MAXCYTE INC revenue, earnings and financials

For the quarter ended June 30, 2026, MAXCYTE INC reported revenue of $7.27M (down 14.5% from a year earlier), net income of −$8.87M and diluted EPS of −$0.08; over the last four quarters revenue was $31.1M and net income −$35.6M; for the fiscal year ended December 2025 revenue was $33.0M, down 14.5% on the year before.

MXCT annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $33.0M, gross profit $26.8M, operating income −$51.9M, net income −$44.6M (margin -135.1%), EPS −$0.42
• Fiscal year ended Dec 2024: revenue $38.6M, gross profit $31.5M, operating income −$51.2M, net income −$41.1M (margin -106.3%), EPS −$0.39
• Fiscal year ended Dec 2023: revenue $41.3M, gross profit $36.5M, operating income −$48.3M, net income −$37.9M (margin -91.8%), EPS −$0.37
• Fiscal year ended Dec 2022: revenue $44.3M, gross profit $39.2M, operating income −$27.4M, net income −$23.6M (margin -53.3%), EPS −$0.23
• Fiscal year ended Dec 2021: revenue $33.9M, gross profit $30.2M, operating income −$18.2M, net income −$19.1M (margin -56.3%), EPS −$0.21

MXCT quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $7.27M (down 14.5% year over year), net income −$8.87M, EPS −$0.08
• Quarter ended Mar 31, 2026: revenue $9.65M (down 7.1% year over year), net income −$4.75M, EPS −$0.04
• Quarter ended Dec 31, 2025 (from the annual report): revenue $7.30M (down 16.0% year over year), net income −$9.60M, EPS −$0.08
• Quarter ended Sep 30, 2025: revenue $6.83M (down 16.4% year over year), net income −$12.4M, EPS −$0.12
• Quarter ended Jun 30, 2025: revenue $8.51M (down 18.4% year over year), net income −$12.4M, EPS −$0.12
• Quarter ended Mar 31, 2025: revenue $10.4M (down 8.4% year over year), net income −$10.3M, EPS −$0.10
• Quarter ended Dec 31, 2024 (from the annual report): revenue $8.69M (down 44.5% year over year), net income −$10.6M, EPS n/a
• Quarter ended Sep 30, 2024: revenue $8.16M (up 2.0% year over year), net income −$11.6M, EPS −$0.11
• Quarter ended Jun 30, 2024: revenue $10.4M (up 15.3% year over year), net income −$9.38M, EPS −$0.09
• Quarter ended Mar 31, 2024: revenue $11.3M (up 32.3% year over year), net income −$9.53M, EPS n/a
• Quarter ended Dec 31, 2023 (from the annual report): revenue $15.7M (up 26.1% year over year), net income −$5.28M, EPS −$0.05
• Quarter ended Sep 30, 2023: revenue $8.00M (down 24.8% year over year), net income −$11.3M, EPS −$0.11
• Quarter ended Jun 30, 2023: revenue $9.04M (down 5.9% year over year), net income −$10.5M, EPS −$0.10
• Quarter ended Mar 31, 2023: revenue $8.58M (down 26.0% year over year), net income −$10.9M, EPS −$0.11
• Quarter ended Dec 31, 2022 (from the annual report): revenue $12.4M (up 22.4% year over year), net income −$4.81M, EPS −$0.05
• Quarter ended Sep 30, 2022: revenue $10.6M (up 5.0% year over year), net income −$6.43M, EPS −$0.06
• Quarter ended Jun 30, 2022: revenue $9.61M (up 35.2% year over year), net income −$8.26M, EPS −$0.08
• Quarter ended Mar 31, 2022: revenue $11.6M (up 78.4% year over year), net income −$4.07M, EPS −$0.04
• Quarter ended Dec 31, 2021 (from the annual report): revenue $10.2M, net income −$4.87M, EPS −$0.04
• Quarter ended Sep 30, 2021: revenue $10.1M, net income −$2.68M, EPS −$0.03

MXCT cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$34.4M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$27.6M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$21.7M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$14.8M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$10.7M, share buybacks n/a

MXCT balance sheet

• Jun 30, 2026: cash $15.0M, total assets $185M, total liabilities $25.9M, shareholders' equity $159M
• Mar 31, 2026: cash $14.6M, total assets $194M, total liabilities $26.6M, shareholders' equity $168M
• Dec 31, 2025: cash $20.1M, total assets $203M, total liabilities $31.0M, shareholders' equity $171M
• Sep 30, 2025: cash $13.0M, total assets $213M, total liabilities $33.2M, shareholders' equity $180M
• Jun 30, 2025: cash $15.2M, total assets $220M, total liabilities $29.0M, shareholders' equity $191M
• Mar 31, 2025: cash $23.4M, total assets $230M, total liabilities $30.5M, shareholders' equity $199M
• Dec 31, 2024: cash $27.9M, total assets $239M, total liabilities $33.2M, shareholders' equity $206M
• Sep 30, 2024: cash $37.0M, total assets $249M, total liabilities $35.3M, shareholders' equity $213M

What is MXCT's revenue?

MAXCYTE INC reported $31.1M of revenue over its last four quarters, through June 30, 2026.

Is MXCT profitable?

No. MAXCYTE INC lost $35.6M over the last four quarters.

What is MXCT's EPS?

Diluted earnings per share over the last four quarters were −$0.32; −$0.08 in the latest quarter.

MXCT ownership and insider trades · All stocks